跳至主要内容
临床试验/JPRN-UMIN000032616
JPRN-UMIN000032616招募中未知

Multi-center, prospective study for novel biomarkers of acute liver failure in adults - Multi-center, prospective study for novel biomarkers of acute liver failure in adults

Keio University, School of Medicine0 个研究点目标入组 200 人开始时间: 2018年5月16日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
16years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • HCC or other malignancies; MOF before liver failure; paraproteinosis; obstructive jaundice

研究者

相似试验

进行中(未招募)
1 期
A Study to Explore the Mechanism of Action of Ocrelizumab and B-cell Biology in Patients with Relapsing Multiple Sclerosis or Primary Progressive Multiple Sclerosis.
EUCTR2015-004616-37-DEGENENTECH Inc.96
进行中(未招募)
1 期
A Study to Explore the Mechanism of Action of Ocrelizumab and B-cell Biology in Patients with Relapsing Multiple Sclerosis or Primary Progressive Multiple SclerosisRelapsing Multiple Sclerosis (RMS)/Primary Progressive Multiple Sclerosis (PPMS)MedDRA version: 20.1Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 21.1Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 21.1Level: PTClassification code 10063401Term: Primary progressive multiple sclerosisSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2015-004616-37-SEGENENTECH Inc.96
尚未招募
不适用
This is an observational trial planned to study the levels of biomarkers bio-ADM and penKid for shock/multiorgan failure in patients with sepsis (also known as blood poisoning).
CTRI/2023/01/048819Rivaara Labs Pvt. Ltd.
已完成
不适用
A Multicenter Study on Biomarker Development Utilizing AI Multiomics for Patients with Advanced Solid Malignant TumorsAdvanced Solid Malignancies
JPRN-UMIN000043899ational Cancer Center Hospital East2,768
已完成
不适用
Study on biomarkers for the effect and safety of the treatment with Atezolizumab + Bevacizumab for liver cancerunresectable advanced hepatocellular carcinoma
JPRN-UMIN000047758agoya University Graduate School of Medicine99